These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9442496)

  • 21. [Risperidon: an advance for schizophrenic patients. Why new neuroleptics?].
    Nervenarzt; 1994 May; 65(5 Suppl [risperid]):1-4. PubMed ID: 9131087
    [No Abstract]   [Full Text] [Related]  

  • 22. [Risperidon--contribution to an integrated therapy of schizophrenia. Yearly session of the German Society for Psychiatry, Psychotherapy and Neurology. Düsseldorf, 17 September 1996].
    Fortschr Neurol Psychiatr; 1996 Dec; 64(12 Suppl):1-4. PubMed ID: 9131062
    [No Abstract]   [Full Text] [Related]  

  • 23. Effectiveness of risperidone in simple schizophrenia: a single case report.
    Hirose S
    J Clin Psychiatry; 2000 Apr; 61(4):300-1. PubMed ID: 10830153
    [No Abstract]   [Full Text] [Related]  

  • 24. Combining risperidone with standard neuroleptics for refractory schizophrenic patients.
    Bacher NM; Kaup BA
    Am J Psychiatry; 1996 Jan; 153(1):137. PubMed ID: 8540580
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of risperidone on polydipsia and hyponatremia in schizophrenia.
    Landry P
    Can J Psychiatry; 1995 Nov; 40(9):566-7. PubMed ID: 8574992
    [No Abstract]   [Full Text] [Related]  

  • 26. [Schizophrenia and quality of life--new definition of therapeutic targets].
    Fortschr Neurol Psychiatr; 1997 Nov; 65(11 Suppl Schizophre):1-4. PubMed ID: 9431352
    [No Abstract]   [Full Text] [Related]  

  • 27. Risperidone in the treatment of catatonia in a schizophrenic patient.
    Poyurousky M; Bergman J; Weizman A
    Isr J Psychiatry Relat Sci; 1997; 34(4):323-4. PubMed ID: 9409090
    [No Abstract]   [Full Text] [Related]  

  • 28. Risperidone is effective in severe hemichorea/hemiballismus.
    Evidente VG; Gwinn-Hardy K; Caviness JN; Alder CH
    Mov Disord; 1999 Mar; 14(2):377-9. PubMed ID: 10091643
    [No Abstract]   [Full Text] [Related]  

  • 29. First person account: living with the delusions and effects of schizophrenia.
    Weiner SK
    Schizophr Bull; 2003; 29(4):877-9. PubMed ID: 14989422
    [No Abstract]   [Full Text] [Related]  

  • 30. Quality-of-life assessment in schizophrenia: the unfulfilled promise.
    Awad AG
    Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):491-3. PubMed ID: 21958091
    [No Abstract]   [Full Text] [Related]  

  • 31. [Non-dopaminergic drugs in schizophrenia].
    Llorca PM
    Encephale; 2006 Oct; 32(5 Pt 4):S913-6; discussion S917. PubMed ID: 17119505
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of a rare psychopathological phenomenon: tactile hallucinations and the delusional other.
    Heveling T; Emrich HM; Dietrich DE
    Eur Psychiatry; 2004 Sep; 19(6):387-8. PubMed ID: 15363483
    [No Abstract]   [Full Text] [Related]  

  • 33. British Association for Psychopharmacology--2008 Summer Meeting.
    Jenkins TA
    IDrugs; 2008 Oct; 11(10):720-3. PubMed ID: 18828070
    [No Abstract]   [Full Text] [Related]  

  • 34. Potential control of risperidone-related cognitive deficits by adjunctive aripiprazole treatment.
    Hu CH; Pai N; Huang XF; Deng C
    J Clin Psychopharmacol; 2011 Feb; 31(1):135-6; author reply 136-7. PubMed ID: 21192163
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic use of neuroleptics. Satellite symposium "Risperdal: new horizons for the schizophrenic patient". 9th World Congress for Psychiatry, Rio de Janeiro, 6-12 June 1993].
    Nervenarzt; 1993 Nov; 64(11 Suppl):1-8. PubMed ID: 7477597
    [No Abstract]   [Full Text] [Related]  

  • 36. Risperidol and withdrawal bruxism in Lewy body dementia.
    Shiwach RS; Woods S
    Int J Geriatr Psychiatry; 1998 Jan; 13(1):65-6. PubMed ID: 9489584
    [No Abstract]   [Full Text] [Related]  

  • 37. Risperidone and sulpiride: Brands vs generics.
    Andrade C
    Schizophr Res; 2018 Mar; 193():486. PubMed ID: 28821357
    [No Abstract]   [Full Text] [Related]  

  • 38. New perspectives and directions in schizophrenia therapeutics: advances related to non-dopaminergic systems.
    Al-Nuaimi S; Chaves C; Hallak JE; Baker GB; Dursun S
    Braz J Psychiatry; 2010 Dec; 32(4):333-8. PubMed ID: 21308251
    [No Abstract]   [Full Text] [Related]  

  • 39. What is the right pharmacotherapy for alcohol use disorder in patients with schizophrenia?
    Batki SL
    J Clin Psychiatry; 2015 Oct; 76(10):e1336-7. PubMed ID: 26528663
    [No Abstract]   [Full Text] [Related]  

  • 40. How to best treat patients with schizophrenia and co-occurring alcohol use disorder.
    Petrakis IL
    J Clin Psychiatry; 2015 Oct; 76(10):e1338-9. PubMed ID: 26528664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.